BMT Interest Group - Pharmacists Posts - TopicsExpress

he imaFinally a HSCT presentation in the ASH plenary! 3 A Novel
he imaFinally a HSCT presentation in the ASH plenary! 3 A Novel Th17-Prone CD146+CCR5+ T-Cell Population As an Early Marker of Intestinal Graft-Versu...

FDA designates isavuconazole QIDP drug Astellas recently
FDA designates isavuconazole QIDP drug Astellas recently announced that the FDA has designated its antifungal agent isavuconazole as a qualified infe...

SEATTLE, Oct. 7, 2013 -- /PRNewswire/ -- Cell Therapeutics, Inc.
SEATTLE, Oct. 7, 2013 -- /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced that the company reached agreement with ...

The impact of thymoglobulin prior to pediatric unrelated umbilical
The impact of thymoglobulin prior to pediatric unrelated umbilical cord blood transplantation on immune-reconstitution and clinical outcome Caroline A...

EORTC study suggests detection of ERG gene deletion at diagnosis
EORTC study suggests detection of ERG gene deletion at diagnosis of childhood ALL is useful for risk stratification First post on 23 October 2013 R...

[x] close Allogeneic hematopoietic stem cell transplantation in
[x] close Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the EBMT experience Régis Peffault de Latour1,*, Raphael Porcher2, Je...